Follow-The-Filings

Security · featured owners

GANX Gain Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.0%
  • $1M

GANX (Gain Therapeutics Inc.) is held in 1 featured 13F book as of 2026 Q2. David Einhorn - DME Capital Management is the largest tracked holder by portfolio weight (0.03%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.0% (David Einhorn - DME Capital Management) · not free-float ownership

  1. David Einhorn 0.03%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
David Einhorn - DME Capital Management 2026 Q2 0.03% Hold 566,130 $1M History

1 current · options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 5.07 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
4 Period Jul 15, 2026 · 6 forms Filing Doc
4 Period Mar 24, 2026 · 2 forms Filing Doc
4 Period Jun 24, 2025 · 4 forms Filing Doc

Updated 2 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $55,180 — —
Net income -$22.27M -$20.41M -$20.16M
Net margin * -40354.3% — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $17.78M $11.6M $22.24M
Total non-current assets $830,463 $521,406 $581,837
Total assets $18.61M $12.12M $22.82M
Total current liabilities $4.95M $3.91M $3.35M
Total non-current liabilities $1.08M $0.873M $0.902M
Total equity $12.58M $7.34M $18.56M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$18.87M -$18.87M -$18.47M
Cash from investing $10.22M $4.98M —
Cash from financing $12.64M $13.01M $28.45M
Net change in cash $4.49M -$1.41M $10.46M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders